What is Me-better in Life Sciences?

Me-better class of innovative drugs refers to new drugs that have clinical efficacy or safety superior to that of the original innovative drug. Generally speaking, since the target of action of this type of innovative drug has not changed, its clinical risk is relatively small, and many innovative drugs have established their positions in the clinic, showing good market performance. Because these drugs are highly recognized by the public, their market research and development costs are relatively low.